Day One Biopharmaceuticals, Inc.
DAWN
Revenue
93.76M
▲93.76M∞%
12 Months ChangeAssets
600.81M
▲200.37M▲50.04%
3 Months ChangeLiabilities
45.34M
▼-48.36M▼-51.61%
3 Months ChangeFree Cash Flow
-49.73M
▼-23.72M▼-91.18%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 10-Q
ID: 0000950170-24-118958
2024-10-30
Form 8-K
ID: 0000950170-24-118950
2024-08-02
Form 10-Q
ID: 0000950170-24-089945
2024-07-30
Form 8-K
ID: 0000950170-24-087505
2024-07-30
Form 8-K
ID: 0001193125-24-188235
2024-07-25
Form 8-K
ID: 0001193125-24-184249
2024-06-18
Form 8-K
ID: 0001193125-24-163081
2024-06-12
Form 8-K
ID: 0001193125-24-159611
2024-05-30
Form 8-K
ID: 0001193125-24-149895
2024-05-24
Form 8-K
ID: 0001193125-24-147015